Our results add to the growing literature surrounding synthetic lethal targeting of tumor metabolism
Our strength lies in our team of internationally trained dermatologists, each with expertise in their specialized fields
Disruption of this integrated network (e.g., via ferroptosis inhibitors targeting ACSL4/GPX4, anti-inflammatory agents blocking HMGB1/IL-33, or HIF modulators balancing hypoxia adaptation) can break the pathogenic cycle, highlighting the therapeutic potential of targeting the networks central nodes rather than individual pathways
For those looking for evidence-based ways to support their health, peptide therapy offers a way to work with the bodys own regulatory systems, rather than overriding them
Endpoints News reports that the PBM conducted an insurance claims analysis of 3,364 obese patients (body mass index greater than 30) who had started taking a GLP-1 during 2021 and were continuously enrolled with a commercial insurer